Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Name: Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
License: Public Domain

British Columbia Cancer Agency

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

squamous-cell-carcinoma

locally advanced squamous cell carcinomas of the head and neck (scchn), squamous cell carcinoma, head and neck, neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Related documents